Leonidou L, Mouzaki A, Michalaki M, DeLastic AL, Kyriazopoulou V, Bassaris HP, Gogos CA. Cytokine production and hospital mortality in patients with sepsis-induced stress hyperglycemia. J Infect. 2007;55:340–6. https://doi.org/10.1016/j.jinf.2007.05.177
McCowen KC, Malhotra A, Bistrian BR. Stress-induced hyperglycemia. Crit Care Clin. 2001;17:107–24. https://doi.org/10.1016/s0749-0704(05)70154-8
Article CAS PubMed Google Scholar
Marik PE, Raghavan M. Stress-hyperglycemia, insulin and immunomodulation in sepsis. Intensive Care Med. 2004;30:748–56. https://doi.org/10.1007/s00134-004-2167-y
Stentz FB, Umpierrez GE, Cuervo R, Kitabchi AE. Proinflammatory cytokines, markers of cardiovascular risks, oxidative stress, and lipid peroxidation in patients with hyperglycemic crises. Diabetes. 2004;53:2079–86. https://doi.org/10.2337/diabetes.53.8.2079
Article CAS PubMed Google Scholar
Esposito K, Nappo F, Marfella R, Giugliano G, Giugliano F, Ciotola M, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans: role of oxidative stress. Circulation. 2002;106:2067–72. https://doi.org/10.1161/01.cir.0000034509.14906.ae
Article CAS PubMed Google Scholar
Angeli F, Reboldi G, Poltronieri C, Lazzari L, Sordi M, Garofoli M, et al. Hyperglycemia in acute coronary syndromes: from mechanisms to prognostic implications. Ther Adv Cardiovasc Dis. 2015;9:412–24. https://doi.org/10.1177/1753944715594528
Article CAS PubMed Google Scholar
Capes SE, Hunt D, Malmberg K, Gerstein HC. Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview. Lancet. 2000;355:773–8. https://doi.org/10.1016/S0140-6736(99)08415-9
Article CAS PubMed Google Scholar
Cheng S-Y, Wang H, Lin S-H, Wen J-H, Ma L-L, Dai X-C. Association of admission hyperglycemia and all-cause mortality in acute myocardial infarction with percutaneous coronary intervention: a dose-response meta-analysis. Front Cardiovasc Med. 2022;9:932716. https://doi.org/10.3389/fcvm.2022.932716
Article CAS PubMed PubMed Central Google Scholar
Dziewierz A, Giszterowicz D, Siudak Z, Rakowski T, Dubiel JS, Dudek D. Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with acute myocardial infarction. Clin Res Cardiol. 2010;99:715–21. https://doi.org/10.1007/s00392-010-0175-1
Li D, Hua Q, Guo J, Li H, Chen H, Zhao S. Admission glucose level and in-hospital outcomes in diabetic and non-diabetic patients with ST-elevation acute myocardial infarction. Intern Med. 2011;50:2471–5. https://doi.org/10.2169/internalmedicine.50.5750
Article CAS PubMed Google Scholar
Schmitz T, Freuer D, Harmel E, Heier M, Peters A, Linseisen J, Meisinger C. Prognostic value of stress hyperglycemia ratio on short- and long-term mortality after acute myocardial infarction. Acta Diabetol. 2022;59:1019–29. https://doi.org/10.1007/s00592-022-01893-0
Article CAS PubMed PubMed Central Google Scholar
Meisinger C, Hörmann A, Heier M, Kuch B, Löwel H. Admission blood glucose and adverse outcomes in non-diabetic patients with myocardial infarction in the reperfusion era. Int J Cardiol. 2006;113:229–35. https://doi.org/10.1016/j.ijcard.2005.11.018
Butkowski EG, Jelinek HF. Hyperglycaemia, oxidative stress and inflammatory markers. Redox Rep. 2017;22:257–64. https://doi.org/10.1080/13510002.2016.1215643
Article CAS PubMed Google Scholar
Liu N, Sheng J, Wang Y. Effect of stress hyperglycaemia on monocyte chemoattractant protein-1 levels and the short-term prognosis of patients with acute ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention. Exp Ther Med. 2019;17:3823–9. https://doi.org/10.3892/etm.2019.7338
Article CAS PubMed PubMed Central Google Scholar
Löwel H, Meisinger C, Heier M, Hörmann A. The population-based acute myocardial infarction (AMI) registry of the MONICA/KORA study region of Augsburg. Gesundheitswesen. 2005;67(Suppl 1):S31–7. https://doi.org/10.1055/s-2005-858241
Kuch B, Heier M, von Scheidt W, Kling B, Hoermann A, Meisinger C. 20-year trends in clinical characteristics, therapy and short-term prognosis in acute myocardial infarction according to presenting electrocardiogram: the MONICA/KORA AMI Registry (1985–2004). J Intern Med. 2008;264:254–64. https://doi.org/10.1111/j.1365-2796.2008.01956.x
Article CAS PubMed Google Scholar
Olink Proteomics. Normalized protein eXpression. https://www.olink.com/faq/what-is-npx/
Ponce-de-Leon M, Linseisen J, Peters A, Linkohr B, Heier M, Grallert H, et al. Novel associations between inflammation-related proteins and adiposity: a targeted proteomics approach across four population-based studies. Transl Res. 2022;242:93–104. https://doi.org/10.1016/j.trsl.2021.11.004
Article CAS PubMed Google Scholar
Szczepańska E, Gietka-Czernel M. FGF21: a Novel Regulator of glucose and lipid metabolism and whole-body Energy Balance. Horm Metab Res. 2022;54:203–11. https://doi.org/10.1055/a-1778-4159
Article CAS PubMed Google Scholar
Schmitz T, Harmel E, Heier M, Peters A, Linseisen J, Meisinger C. Inflammatory plasma proteins predict short-term mortality in patients with an acute myocardial infarction. J Transl Med. 2022;20:457. https://doi.org/10.1186/s12967-022-03644-9
Article CAS PubMed PubMed Central Google Scholar
Haybar H, Bandar B, Torfi E, Mohebbi A, Saki N. Cytokines and their role in cardiovascular diseases. Cytokine. 2023;169:156261. https://doi.org/10.1016/j.cyto.2023.156261
Article CAS PubMed Google Scholar
Zietz B, Büchler C, Herfarth H, Müller-Ladner U, Spiegel D, Schölmerich J, Schäffler A. Caucasian patients with type 2 diabetes mellitus have elevated levels of monocyte chemoattractant protein-1 that are not influenced by the– 2518 A–G promoter polymorphism. Diabetes Obes Metab. 2005;7:570–8. https://doi.org/10.1111/j.1463-1326.2004.00436.x
Article CAS PubMed Google Scholar
Simeoni E, Hoffmann MM, Winkelmann BR, Ruiz J, Fleury S, Boehm BO, et al. Association between the A-2518G polymorphism in the monocyte chemoattractant protein-1 gene and insulin resistance and type 2 diabetes mellitus. Diabetologia. 2004;47:1574–80. https://doi.org/10.1007/s00125-004-1494-4
Article CAS PubMed Google Scholar
Whelan CD, Mattsson N, Nagle MW, Vijayaraghavan S, Hyde C, Janelidze S, et al. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer’s disease. Acta Neuropathol Commun. 2019;7:169. https://doi.org/10.1186/s40478-019-0795-2
Article CAS PubMed PubMed Central Google Scholar
Fineschi S, Klar J, Gustafsson KA, Jonsson K, Karlsson B, Dahl N. Inflammation and Interferon Signatures in Peripheral B-Lymphocytes and Sera of individuals with Fibromyalgia. Front Immunol. 2022;13:874490. https://doi.org/10.3389/fimmu.2022.874490
Article CAS PubMed PubMed Central Google Scholar
Aversa J, Song M, Shimazu T, Inoue M, Charvat H, Yamaji T, et al. Prediagnostic circulating inflammation biomarkers and esophageal squamous cell carcinoma: a case-cohort study in Japan. Int J Cancer. 2020;147:686–91. https://doi.org/10.1002/ijc.32763
Article CAS PubMed Google Scholar
Isvoran A, Peng Y, Ceauranu S, Schmidt L, Nicot AB, Miteva MA. Pharmacogenetics of human sulfotransferases and impact of amino acid exchange on phase II drug metabolism. Drug Discov Today. 2022;27:103349. https://doi.org/10.1016/j.drudis.2022.103349
Comments (0)